Diabetic Gastroparesis Efficacy/Safety Study of TZP-102
Public ClinicalTrials.gov record NCT01664637. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Evaluation of the Efficacy and Safety of TZP-102 Given Orally Three Times a Day for the Treatment of Symptoms Associated With Diabetic Gastroparesis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to test the safety and effectiveness of 10 mg TZP-102 given prior to meals three times a day compared to placebo (capsule that looks like active study drug but contains no active drug), administered for 12 weeks, in diabetic subjects with symptoms associated with gastroparesis.
Study identification
- NCT ID
- NCT01664637
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2012 (Type not available)
- Primary completion
- Jan 2013 (Estimated)
- Completion
- Feb 2013 (Estimated)
- Last update posted
- Dec 20, 2012
2012 – 2013
United States locations
- U.S. sites
- 23
- U.S. states
- 14
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Tranzyme Investigational Site | Huntsville | Alabama | 35801 | — |
| Tranzyme Investigational Site | Tucson | Arizona | 85710 | — |
| Tranzyme Investigational Site | North Little Rock | Arkansas | 72117 | — |
| Tranzyme Investigational Site | Long Beach | California | 90822 | — |
| Tranzyme Investigational Site | Ventura | California | 93003 | — |
| Tranzyme Investigational Site | Hialeah | Florida | 33016 | — |
| Tranzyme Investigational Site | Inverness | Florida | 34452 | — |
| Tranzyme Investigational Site | Jacksonville | Florida | 32256 | — |
| Tranzyme Investigational Site | Miami | Florida | 33144 | — |
| Tranzyme Investigational Site | Miami | Florida | 33183 | — |
| Tranzyme Investigational Site | New Smyrna Beach | Florida | 32168 | — |
| Tranzyme Investigational Site | Anderson | Indiana | 46106 | — |
| Tranzyme Investigational Site | Indianapolis | Indiana | 46202 | — |
| Tranzyme Investigational Site | Kansas City | Kansas | 66160 | — |
| Tranzyme Investigational Site | Monroe | Louisiana | 71201 | — |
| Tranzyme Investigational Site | Boston | Massachusetts | 02215 | — |
| Tranzyme Investigational Site | Mexico | Missouri | 65265 | — |
| Tranzyme Investigational Site | Raleigh | North Carolina | 27612 | — |
| Tranzyme Investigational Site | Salisbury | North Carolina | 28144 | — |
| Tranzyme Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Tranzyme Investigational Site | Oklahoma City | Oklahoma | 73104 | — |
| Tranzyme Investigational Site | Portland | Oregon | 97210 | — |
| Tranzyme Investigational Site | El Paso | Texas | 79905 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01664637, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 20, 2012 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01664637 live on ClinicalTrials.gov.